Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Epoetin alfa and darbepoetin alfa may cause the body to make more red blood cells.
They are used to treat anemia caused by chemotherapy in patients with cancer.
PURPOSE: This randomized clinical trial is studying four different schedules of epoetin alfa
or darbepoetin alfa to compare how well they work in treating patients with anemia caused by
chemotherapy.